Reduce the HFD-induced body weight, liver weight, AST and ALT levels, macrophage infiltration, proinflammatory cytokines production and NAFLD activity score; directly binding with MD2 to compete the binding of MD2 with TLR4. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.